StreetAlpha.app
Home › Stocks › BHVN

Biohaven Ltd. (BHVN)

Healthcare
$12.39
▼ −9.23%
LAST CLOSE · NOV 20

Biohaven is a New Haven, Connecticut biopharmaceutical company developing treatments for immune, nerve and metabolic diseases. It last closed at $12.39 on Nov 20, down 9.23% on the day. The next earnings report for BHVN is expected around Mon, Mar 1, 2027, after the close. For the quarter ended Sep 2026, BHVN reported EPS of -$0.86. Over its last 8 reports the stock moved an average of 4.3% the session after earnings.

AI Auto Pilots
Is BHVN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold BHVN.

Key Stats

Last 12 months
Results
Net income
−$542.7M
EPS (diluted)
−$3.77
Free cash flow
−$473.2M
Valuation
Market cap
$1.9B
151.1M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$95.8M
At Sep 30
Debt
$264.3M
At Sep 30
Shareholder equity
−$98.2M
Shares outstanding
151.1M
At Oct 26
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: −$213.8M−$213.8MFY2021FY2022: −$570.3M−$570.3MFY2022FY2023: −$408.2M−$408.2MFY2023FY2024: −$846.4M−$846.4MFY2024FY2025: −$738.8M−$738.8MFY2025

From BHVN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 29). Last 12 months adds up the four latest quarters.

Next report
Mar 1
Estimated date · After the close
Reported EPS
-$0.86
Quarter ended Sep 2026
Year ago EPS
-$1.64
Same quarter last year
Revenue
—
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$1.78Dec '24Mar 2025: -$2.17Mar '25Jun 2025: -$1.94Jun '25Sep 2025: -$1.64Sep '25Dec 2025: -$1.12Dec '25Mar 2026: -$0.88Mar '26Jun 2026: -$0.91Jun '26Sep 2026: -$0.86Sep '26Latest -$0.86
Revenue by quarter
Not enough quarters on file yet.
How BHVN moved after its last 8 reports
Average move the session after a report ±4.3%
Oct 29, 2026After the close−6.5%
Aug 10, 2026After the close−0.3%
May 4, 2026After the close−4.2%
Mar 2, 2026After the close−9.7%
Nov 10, 2025Time not announced−5.7%
Aug 11, 2025After the close+0.5%
May 12, 2025After the close−5.1%
Mar 3, 2025After the close−2.1%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on BHVNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on BHVN
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on BHVN

Technical Analysis

BHVN · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold

The stock is 17% below its 20 day and 8% below its 50 day average. It is sitting right on its 200 day average, a level many traders watch. Momentum is weak (RSI 41), near oversold. The nearest support is the 200 day average at $12.37, and the nearest resistance the Pivot at $12.82.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 8.3%/day
Key levels
$18.2452 week high+47.2%
$14.5520 day average+17.4%
$14.08100 day average+13.6%
$13.62Swing high (Sep 30)+9.9%
$13.4250 day average+8.3%
$13.32Pivot R1+7.5%
$12.82Pivot+3.5%
$12.39Last close
$12.37200 day average−0.2%
$11.93Swing low (Sep 16)−3.7%
$11.88Pivot S1−4.1%
$8.0352 week low−35.2%
Indicators
RSI (14)40.64Middle of its rangeNeutral
MACD-0.12Below its signal lineBearish
Stochastic8.9Near the bottom of its rangeOversold
ADX (14)20.4Weak trend
Williams %R-97.9Oversold below −80, overbought above −20Oversold
CCI (20)-149.4Oversold below −100, overbought above 100Oversold
Rate of change−14.4%Change over 10 sessionsBearish
ATR (14)$1.03Typical daily range, 8.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for BHVN

What happened before

See how BHVN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow BHVN usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How BHVN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2017.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for BHVNHow many large options trades hit BHVN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

BHVN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●136 buying vs 131 selling
  • ●Held by funds +0.1 pts
  • ▲Funds holding +11
  • ▼Superinvestors: 2 added, 3 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding306295+3.7%
In funds' top 1089−11.1%
Held by funds93.6%93.4%+0.1 pts
New / increased48 / 8849 / 108−13.4%
Reduced / sold out93 / 3887 / 33+9.2%
Put/call ratio0.160.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BHVN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

BHVN Insider Trading

All filings →
Insider trading · 12 months
No open market trades in 12 months
Bought$00 buys · 0 insiders
Sold$00 sales · 0 insiders
DecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 17, 2025George C. ClarkVP, Chief Accounting OfficerBuy17,000$8.52$145K
Nov 13, 2025John W ChildsDirectorBuy3,333,333$7.50$25.0M
Nov 13, 2025Vlad CoricCEOBuy666,666$7.50$5.0M
Nov 13, 2025Gregory BaileyDirectorBuy400,000$7.50$3.0M
Mar 4, 2025John W ChildsDirectorBuy32,700$30.47$996K
Dec 30, 2024John W ChildsDirectorBuy29,000$35.94$1.0M
Every insider buy and sale for BHVN over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See BHVN insider trades →

From SEC Form 4 filings by BHVN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BHVN is in one of them and how their past BHVN trades turned out.

BHVN in the AI portfolios
Loading…

BHVN News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BHVN in an article yet. Here's the latest on the wider market.

BHVN in the news

About Biohaven

Biohaven is a biopharmaceutical company based in New Haven, Connecticut. It develops treatments in immunology, neuroscience and oncology. Its main programs include a group of drugs that remove disease-causing proteins from the body for immune conditions such as Graves' disease and IgA nephropathy, a candidate for epilepsy, and a program for muscle and metabolic conditions, including obesity. Its treatments are aimed at patients with these diseases.

Headquarters
New Haven, CT